The aim of this study is to evaluate intracervical lidocaine gel as a means to decrease pain associated with intrauterine device (IUD) insertion. They will be randomized to either placebo (inert water based lubricating gel) or 2% lidocaine gel to be placed intracervically via angio-catheter just before IUD insertion. Anticipated pain scores will be assessed using a visual analog scale prior to insertion. Using the same pain scale, patients will again be asked at the end of the procedure to rate their pain.

Using a visual analog scale, women will report their level of pain pre-procedure, after tenaculum placement, and post-procedure.The entirety of teh procedure should last no more than 5-10 minuites. The pain score is assessed at the 3 timepoints within that 10 minuite window. No additional followup is required.

Women randomized to the Lidocaine arm will receive a total of 3-5cc of 2% gel at the tenaculum site and within the endocervical canal

Drug: 2% lidocaine gel

3-5cc of 2% lidocaine gel will be applied to the lip of the cervix and within the endocervical canal prior to IUD insertion

Placebo Comparator: Water based lubricant

Women randomized to the placebo arm will receive a total of 3-5cc of water based lubricant at the tenaculum site and within the the endocervical canal

Drug: Water based lubricant

3-5cc of water based lubricant will be applied to the lip of the cervix and within the endocervical canal prior to IUD insertion

Eligibility

Ages Eligible for Study:

18 Years to 45 Years

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

age 18-45 yrs

selecting intrauterine device contraception

able and willing to consent

Exclusion Criteria:

non-English speaking

current intrauterine device use

expulsion of intrauterine device within 2 weeks

allergy to lidocaine or water based lubricant

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01411995